DBV Technologies (DBVT) Total Debt (2014 - 2020)
DBV Technologies (DBVT) reported Total Debt of $1.4 million for Q2 2020, down 18.09% year-over-year from $1.8 million in Q3 2019, and up 0.89% on a QoQ basis from $1.4 million in Q4 2019.
DBV Technologies (DBVT) has 7 years of Total Debt data on file, last reported at $1.4 million in Q2 2020.
- Quarterly Total Debt fell 18.09% year-over-year to $1.4 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $1.4 million (down 18.09% YoY) and the FY2019 annual result came in at $1.4 million, down 49.22% from the prior year.
- Total Debt rose to $1.4 million in Q2 2020 per DBVT's latest filing, from $1.4 million in the prior quarter.
- Across five years, Total Debt topped out at $5.4 million in Q2 2016 and bottomed at $1.4 million in Q4 2019.
- The 5-year median for Total Debt is $3.6 million (2018), against an average of $3.4 million.
- The widest annual swing landed in 2016, when Total Debt gained 1.18%; it then slumped 58.79% in 2019.
- Tracing DBVT's Total Debt over 5 years: stood at $5.0 million in 2016, then fell by 2.47% to $4.9 million in 2017, then tumbled by 42.09% to $2.8 million in 2018, then sank by 49.22% to $1.4 million in 2019, then rose by 0.89% to $1.4 million in 2020.
- Per Business Quant, the three latest DBVT Total Debt figures stand at $1.4 million (Q2 2020), $1.4 million (Q4 2019), and $1.6 million (Q3 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.45 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 1.77 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Jun 30, 2018 | 4.29 Mn |
| Dec 31, 2017 | 4.89 Mn |
| Jun 30, 2017 | 4.91 Mn |
| Dec 31, 2016 | 5.01 Mn |
| Jun 30, 2016 | 5.45 Mn |
| Dec 31, 2015 | 5.31 Mn |
| Jun 30, 2015 | 5.38 Mn |
| Dec 31, 2014 | 5.13 Mn |